Browse > Article

Clinical and microbiologic effects of the subantimicrobial dose of doxycycline on the chronic periodontitis  

Kim, Sang-Jun (Department of Periodontology, School of Dentistry, Kangnung National University)
Um, Heung-Sik (Department of Periodontology, School of Dentistry, Kangnung National University)
Chang, Beom-Seok (Department of Periodontology, School of Dentistry, Kangnung National University)
Lee, Jae-Kwan (Department of Periodontology, School of Dentistry, Kangnung National University)
Publication Information
Journal of Periodontal and Implant Science / v.39, no.1, 2009 , pp. 37-44 More about this Journal
Abstract
Purpose: Tetracycline and its chemically modified non-antibacterial analogues can inhibit certain host-derived tissue destructive collagenases such as matrix metalloproteinases. The purpose of this study was to evaluate clinical and microbiologic effects of the subantimicrobial dose of doxycycline(SDD) in conjunction with scaling and root planing. Materials and methods: A total of 30 patients with chronic periodontitis who were going to receive scaling and root planing were randomly allocated to receive either a doxycycline hyclate for 3 months or nothing. Clinical probing depth, clinical attachment level, gingival recession, and bleeding on probing were measured by one periodontist. After a periodontal examination, microbial samples were collected using sterile paper points. The effect of SDD in conjunction with scaling and root planing on alterations of the periodontal pathogens (Aggregatibacter actinomycetemcomitans, Tannerella forsythia, Porphyromonas gingivalis) were also assessed using l6S rRNA polymerase chain reaction. Results: During the treatment period, clinical parameters for both treatment group and control group were improved. After 3 months, reductions in probing depth and gains in clinical attachment level were significantly greater for the SDD group than control group. Microbial analysis showed that there was no alteration of the periodontal pathogens and no difference between the groups. Conclusion: This study suggested that the subantimicrobial dose of doxycycline as an adjunct therapy with scaling and root planing might be effective and safe in the management of chronic periodontitis.
Keywords
subantimicrobial dose of doxycycline; chronic periodontitis; periodontal pathogen;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Golub LM, McNamara TF, Ryan ME et al. Adjunctive treatment with subantimicrobial doses of doxycycline: effects on gingival fluid collagenase activity and attachment loss in adult periodontitis. J Clin Periodontol 2001;28: 146-156   DOI   ScienceOn
2 Smith GN Ir, Mickler EA, Hasty KA, Brandt KD. Specificity of inhibition of matrix metalloproteinase activity by doxycycline: relationship to structure of thc enzyme. Arthritis Rheum 1999;42:1140-1146   DOI   ScienceOn
3 Position paper. Systemic antibiotics in periodontics. J Periodontol 2004;75:1553-1565   DOI   PUBMED
4 Ashimoto A, Chen C, Bakker I, Slots J. Polymerase chain reaction detection of 8 putative periodontal pathogens in subgingival plaque of gingivitis and advanced periodontitis lesions. Oral Microbiol Immunol 1996; II :266-273   DOI   ScienceOn
5 Offenbacher S, Heasman PA, Collins JG. Modulation of host PGE2 secretion as a determinant of periodontal disease expression. J Periodontol 1993;64(Suppl. 5):432-444   PUBMED
6 Jeong SN, Han SB. The effects of low dose doxycycline regimen on gingival crevicular fluid enzyme activity of diabetic patients with periodontitis and adult periodontitis patients. J Korean Acad Periodontol 1997;27:701-722   DOI
7 Socransky SS, Smith C, Martin L et al. 'Checkerboard' DNA-DNA hybridization. Biotechniques 1994;17:788-792   PUBMED
8 Birkedal-Hansen H, Moore WG, Bodden MK et al. Matrix metalloproteinases: a review. Crit Rev Oral Bioi Med 1993;4:197-250   DOI
9 Birkedal-Hansen H. Role of cytokine and inflammatory mediators in tissue destruction. J Periodontal Res 1993;28: 500-510   DOI   PUBMED   ScienceOn
10 Ryan ME, Ramamurthy NS, Golub LM. Matrix metalloproteinases and their inhibition in periodontal treatment. Curr Opin Periodontol 1996;3:85-96   PUBMED
11 Newman HN. Modes of application of anti-plaque chemicals. J Clin Periodontol 1986; 13:965-974   DOI   PUBMED
12 Golub LM, Wolff M, Lee HM et al. Further evidence that tetracyclines inhibit collagenase activity in human crevicular fluid and from other mammalian sources. J Periodontal Res 1985;20:12-23   DOI   PUBMED
13 Thomas J, Walker C, Bradshaw M. Long-term use of subantimicrobial dose doxycycline does not lead to changes in antimicrobial susceptibility. J Periodontol 2000;71: 1472-1483   DOI   ScienceOn
14 Reynolds H, Mashimo P, Slot J et al. Use of tetracycline in the treatment of periodontitis. II. Microbiological studies. J Dent Res 1978;57:267
15 Golub LM, Ciancio SG, Ramamurthy NS, Leung M, McNamara TF. Low-dose doxycycline therapy: effect on gingival and crevicular fluid collagenase activity in humans. J Periodontal Res 1990;25:321-330
16 Caton JG, Ciancio SG, Blieden TM et al. Treatment with subantimicrobial dose doxycycline improves the efficacy of scaling and root planing in patients with adult periodontitis. J Periodontol 2000;71:521-532   DOI   ScienceOn
17 Newman MG, Takei HH, Klokkevold PR, Carranza FA. Carranza's Clinical Periodontology, 10th ed. Philadelphia: W.B. Saunders; 2006:813-827
18 Dongari-Bagtzoglou AI, Ebersole JL. Production of inflammatory mediators and cytokines by human gingival fibroblasts following bacterial challenge. J Periodontal Res 1996;31:90-98   DOI   PUBMED
19 Howell TH, Williams RC. Nonsteroidal antiinflammatory drugs as inhibitors of periodontal disease progression. Crit Rev Oral Bioi Med 1993;4:177-196   DOI
20 Williams RC, Jeffcoat MK, Howell TH et al. Three year trial of flurbiprofen treatment in humans: post-treatment period. J Dent Res 1991;70:468
21 Thomas JG, Metheny RJ, Karakiozis JM, Wetzel 1M, Crout RJ. Long-term sub-antimicrobial doxycycline(Periostat) as adjunctive management in adult periodontitis: effects on subgingival bacterial population dynamics. Adv Dent Res 1998;12:32-39   DOI   ScienceOn
22 Golub LM, Sorsa T, Lee HM ct al. Doxycycline inhibits neutrophil(PMN)-type matrix metalloproteinases in human adult periodontitis gingiva. J Clin Periodontol 1995;22: 100-109   DOI   PUBMED   ScienceOn
23 Genco RJ. Host responses in periodontal diseases: current concepts. J Periodontol 1992;63(Suppl. 4):338-355   DOI   PUBMED
24 Badersten A, Nilveus R, Egelberg J. Effect of nonsurgical periodontal therapy. I. Moderately advanced periodontitis. J Clin Periodontol 1981 ;8:57 -72   DOI   PUBMED
25 Greenstein G. Local drug delivery in the treatment of periodontal diseases: Assessing the clinical significance of the results. J Periodontol 2006;77 :565-578   DOI   PUBMED   ScienceOn
26 Olsvik B, Tenover F. Tetracycline resistance in periodontal pathogens. Clin 1nfecta Dis 1993;16(Suppl. 4):310-323   DOI   ScienceOn
27 Lee JY, Lee YM, Shin SY et al. Effect of subantimicrobial dose doxycycline as an effective adjunct to scaling and root planing. J Periodontol 2004;75:1500-1508   DOI   ScienceOn
28 Heijl L, Dahlen G, Sundin Y, Wenader A, Goodson JM. A 4-quadrant comparative study of periodontal treatment using tetracycline containing drug delivery fibers and scaling. J Clin Periodontol 1991;18:111-116   DOI   PUBMED
29 Slots J, Rams TE. Antibiotics in periodontal therapy: Advantages and disadvantages. J Clin Periodontol 1990; 17: 479-493   DOI   PUBMED
30 Kim YS, Paik JW, Kim CS, Choi SII, Kim CK. Clinical effect of the subantimicrobial dose of doxycycline(SDD) on the chronic periodontitis. J Korean Acad Periodontol 2002;32:415-425   DOI
31 Ciancio S, Ashley R. Safety and efficacy of sub-antimicrobial- dose doxycycline therapy in patients with adult periodontitis. Adv Dent Res 1998;12:27-31   DOI   ScienceOn